Ned Swanson, CEO, Healthtech Solutions Inc.
Ned Swanson, MD joined Healthtech Solutions Inc. as CEO in May 2021. Prior to joining Healthtech, Dr. Swanson successfully co-founded PolarityTE, Inc. (Nasdaq: PTE), a biotech company that developed and launched SkinTE®, a product that uses the patient’s own skin to regenerate functional skin. Dr. Swanson was a resident in plastic and reconstructive surgery at Johns Hopkins before leaving to co-found PolarityTE, gaining deep experience in clinical/academic medicine and surgery. Before training at Johns Hopkins, he completed undergraduate training in bioengineering at the University of Pennsylvania, his M.D. from Harvard Medical School, and worked in numerous labs investigating traumatic brain injury, pancreatic cancer, transplant immunology, regenerative medicine, and clinical research. Through his work in academic medicine and co-founding a publicly traded biotech company, he recognized the need for tailored investment approaches with operational insight to support the next wave of healthcare innovations – aligning with the vision established at Healthtech to build a portfolio model life sciences company.